Abstract: |
The present disclosure relates to the production of cannabinoids in yeast. In as aspect there is provided a genetically modified yeast comprising: one or more GPP producing genes and optionally, one or more GPP pathway genes; two or more olivetolic acid producing genes; one or more cannabinoid precursor or cannabinoid producing genes; one or more Hexanoyl-CoA producing genes, and at least 5% dry weight of fatty acids or fats. |
Inventor: |
Mikheev, Maxim (Fremont, CA, US); Gao, Difeng (Union City, CA, US) |
Applicant: |
BioMediCan, Inc. (Fremont, CA, US) |
Face Assignee: |
BioMediCan, Inc. (Fremont, CA, US) |
Filed: |
2018-07-12 |
Issued: |
2020-05-28 |
Claims: |
16 |
|
US20200165644
|
1. A genetically modified yeast comprising:
(10)
(5)
|
|